KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Current Leases: 2020-2024

Historic Current Leases for Aurinia Pharmaceuticals (AUPH) over the last 5 years, with Dec 2024 value amounting to $14.0 million.

  • Aurinia Pharmaceuticals' Current Leases rose 9.26% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 million, marking a year-over-year increase of 9.26%. This contributed to the annual value of $14.0 million for FY2024, which is 3.85% down from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Current Leases stood at $14.0 million for FY2024, which was down 3.85% from $14.6 million recorded in FY2023.
  • Over the past 5 years, Aurinia Pharmaceuticals' Current Leases peaked at $14.6 million during FY2023, and registered a low of $788,000 during FY2020.
  • For the 3-year period, Aurinia Pharmaceuticals' Current Leases averaged around $9.9 million, with its median value being $14.0 million (2024).
  • Per our database at Business Quant, Aurinia Pharmaceuticals' Current Leases decreased by 11.61% in 2022 and then skyrocketed by 1,460.79% in 2023.
  • Over the past 5 years, Aurinia Pharmaceuticals' Current Leases (Yearly) stood at $788,000 in 2020, then surged by 34.39% to $1.1 million in 2021, then dropped by 11.61% to $936,000 in 2022, then spiked by 1,460.79% to $14.6 million in 2023, then declined by 3.85% to $14.0 million in 2024.